David Mehalick - CEO and President, Director, 10%+ Owner at Coeptis Therapeutics Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO and President, Director, 10%+ Owner
Issuer Symbol
COEP, COEPW on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David Mehalick since 10 Mar 2025

Holdings reported by David Mehalick for Coeptis Therapeutics Holdings, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 330,192 $4,748,160 $14.38 11 Feb 2026 Direct
Non-Qualified Stock Options (right to buy) 200,125 04 Mar 2025 Direct Common Stock

Transactions reported by David Mehalick for Coeptis Therapeutics Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.